Zymeworks, Inc. (ZYME)
25.46
-0.34
(-1.34%)
USD |
NASDAQ |
Dec 10, 09:40
Zymeworks Profit Margin (Quarterly): -70.99% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Jazz Pharmaceuticals Plc | 22.33% |
| Johnson & Johnson | 21.47% |
| Regeneron Pharmaceuticals, Inc. | 38.89% |
| Vertex Pharmaceuticals, Inc. | 34.76% |
| CorMedix, Inc. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -18.82% |
| Return on Assets | -14.54% |
| Return on Invested Capital | -17.82% |
| Gross Profit Margin (Quarterly) | 90.64% |
| Operating Margin (Quarterly) | -80.07% |
| Return on Net Operating Assets | -82.89% |